Medicaid obesity, sized honestly
How big is a state's Medicaid obesity opportunity — and where does the number stop being trustworthy?
A public-data decision suite that sizes eligibility and prevalence, decomposes the cost (~80% is diabetes and hypertension riding on top of obesity), and tests GLP-1 ROI by comorbid segment — for any U.S. state, with the method on screen.
The bottom-up cost lands within ~6% of the published figure by an independent route — and the suite is explicit about the gaps public data structurally cannot close (the paid wedge), rather than overclaiming.
Open the suite →